These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1105 related articles for article (PubMed ID: 3886560)

  • 1. Distribution of laminin and collagen type-IV in benign and malignant lesions of melanocytic origin.
    Natali PG; Nicotra MR; Bellocci M; Cavaliere R; Bigotti A
    Int J Cancer; 1985 Apr; 35(4):461-7. PubMed ID: 3886560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melanocytes in nevi and melanomas synthesize basement membrane and basement membrane-like material. An immunohistochemical and electron microscopic study including immunoelectron microscopy.
    Schaumburg-Lever G; Lever I; Fehrenbacher B; Möller H; Bischof B; Kaiserling E; Garbe C; Rassner G
    J Cutan Pathol; 2000 Feb; 27(2):67-75. PubMed ID: 10678701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basement membrane deposition in benign and malignant naevo-melanocytic lesions: an immunohistochemical study with antibodies to type IV collagen and laminin.
    Havenith MG; van Zandvoort EH; Cleutjens JP; Bosman FT
    Histopathology; 1989 Aug; 15(2):137-46. PubMed ID: 2777216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minichromosome maintenance protein expression in benign nevi, dysplastic nevi, melanoma, and cutaneous melanoma metastases.
    Boyd AS; Shakhtour B; Shyr Y
    J Am Acad Dermatol; 2008 May; 58(5):750-4. PubMed ID: 18249467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occurrence of basement membranes in pigment cell tumors of the skin, relation to cell type and clinical behavior.
    Stenbäck F; Wasenius VM
    J Cutan Pathol; 1986 Jun; 13(3):175-86. PubMed ID: 3525624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and production of tenascin in benign and malignant lesions of melanocyte lineage.
    Natali PG; Nicotra MR; Bartolazzi A; Mottolese M; Coscia N; Bigotti A; Zardi L
    Int J Cancer; 1990 Oct; 46(4):586-90. PubMed ID: 1698727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The initial steps of tumor progression in melanocytic lineage: a histochemical approach.
    Wollina U; Kilian U; Henkel U; Schaarschmidt H; Knopf B
    Anticancer Res; 1991; 11(4):1405-14. PubMed ID: 1746897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type IV collagen and laminin staining patterns in benign and malignant cutaneous lesions.
    Mackie RM; Clelland DB; Skerrow CJ
    J Clin Pathol; 1989 Nov; 42(11):1173-7. PubMed ID: 2479664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Micro-anatomy related antigen expression in melanocytic lesions.
    Meije CB; Mooi WJ; Le Poole IC; Van Muijen GN; Das PK
    J Pathol; 2000 Apr; 190(5):572-8. PubMed ID: 10727983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HMB-45 recognizes stimulated melanocytes.
    Smoller BR; McNutt NS; Hsu A
    J Cutan Pathol; 1989 Apr; 16(2):49-53. PubMed ID: 2668355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of basement membrane antigens in spindle cell melanoma.
    Prieto VG; Woodruff JM
    J Cutan Pathol; 1998 Jul; 25(6):297-300. PubMed ID: 9694618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The differential reactivity of benign and malignant nevomelanocytic lesions with mouse monoclonal antibody TNKH1.
    Nakanishi T; Hashimoto K
    Cancer; 1987 Apr; 59(7):1340-4. PubMed ID: 3545436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of microtubule-associated protein 2 in benign and malignant melanocytes: implications for differentiation and progression of cutaneous melanoma.
    Fang D; Hallman J; Sangha N; Kute TE; Hammarback JA; White WL; Setaluri V
    Am J Pathol; 2001 Jun; 158(6):2107-15. PubMed ID: 11395388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure of basement membranes in malignant melanoma and nevocytic nevi.
    Schmoeckel C; Stolz W; Sakai LY; Burgeson RE; Timpl R; Krieg T
    J Invest Dermatol; 1989 May; 92(5):663-8. PubMed ID: 2497191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topography of Protein Kinase C βII in Benign and Malignant Melanocytic Lesions.
    Krasagakis K; Tsentelierou E; Chlouverakis G; Stathopoulos EN
    Int J Surg Pathol; 2017 Sep; 25(6):497-501. PubMed ID: 28436290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bcl-2 expression in human melanocytes and melanocytic tumors.
    van den Oord JJ; Vandeghinste N; De Ley M; De Wolf-Peeters C
    Am J Pathol; 1994 Aug; 145(2):294-300. PubMed ID: 8053490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proto-oncogene c-kit expression in malignant melanoma: protein loss with tumor progression.
    Montone KT; van Belle P; Elenitsas R; Elder DE
    Mod Pathol; 1997 Sep; 10(9):939-44. PubMed ID: 9310959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of gelatinase B and the extracellular matrix metalloproteinase inducer EMMPRIN in benign and malignant pigment cell lesions of the skin.
    van den Oord JJ; Paemen L; Opdenakker G; de Wolf-Peeters C
    Am J Pathol; 1997 Sep; 151(3):665-70. PubMed ID: 9284814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Black lesions of the skin.
    BECKER SW
    Calif Med; 1958 Mar; 88(3):228-33. PubMed ID: 13511215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of basement membrane components in eosinophilic globules in a case of Spitz's nevus.
    Schmoeckel C; Stolz W; Burgeson R; Krieg T
    Am J Dermatopathol; 1990 Jun; 12(3):272-4. PubMed ID: 1693820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.